Brokerages Set Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Target Price at $18.86

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) has received an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $19.17.

A number of analysts have commented on the stock. Truist Financial downgraded shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating and dropped their price target for the stock from $18.00 to $17.00 in a research report on Friday, January 17th. JMP Securities raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price on the stock in a report on Tuesday, January 7th. Mizuho reaffirmed a “neutral” rating and set a $20.00 price target on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Finally, Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th.

Institutional Investors Weigh In On Sabra Health Care REIT

Several large investors have recently modified their holdings of SBRA. VSM Wealth Advisory LLC acquired a new stake in shares of Sabra Health Care REIT during the fourth quarter worth $26,000. Quarry LP purchased a new position in Sabra Health Care REIT in the 3rd quarter worth about $30,000. Assetmark Inc. increased its stake in Sabra Health Care REIT by 168.4% in the 3rd quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust’s stock worth $37,000 after purchasing an additional 1,231 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in Sabra Health Care REIT during the 3rd quarter worth about $59,000. Finally, Harbor Capital Advisors Inc. purchased a new stake in Sabra Health Care REIT during the third quarter valued at about $78,000. 99.40% of the stock is owned by institutional investors.

Sabra Health Care REIT Stock Performance

Shares of NASDAQ SBRA opened at $17.09 on Thursday. Sabra Health Care REIT has a 12-month low of $13.31 and a 12-month high of $20.03. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88. The company has a market cap of $4.07 billion, a PE ratio of 32.25, a P/E/G ratio of 1.97 and a beta of 1.27. The stock has a 50 day simple moving average of $16.77 and a 200-day simple moving average of $17.64.

Sabra Health Care REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.36. The company had revenue of $182.35 million during the quarter, compared to analysts’ expectations of $178.01 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. On average, equities research analysts forecast that Sabra Health Care REIT will post 1.45 EPS for the current year.

Sabra Health Care REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were issued a $0.30 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 7.02%. Sabra Health Care REIT’s dividend payout ratio is currently 226.42%.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.